Literature DB >> 22796160

A review of nanocarriers for the delivery of small interfering RNA.

Prashant Kesharwani1, Virendra Gajbhiye, Narendra Kumar Jain.   

Abstract

Increasing knowledge about molecular mechanisms of endogenous RNA interference (RNAi) and small interfering RNAs (siRNAs) has been incorporated into innovative nucleic acid medicines for treatment of diseases such as cancers. Although RNAi and siRNA have the potential to become powerful therapeutic drugs, their delivery to the target site represents a major challenge. The design and creation of nanocarriers for the safe and efficient delivery of siRNA towards their potential applications site is one of the challenging and rapidly growing areas of research since they have to overcome the commonly encountered biological barriers. In this review, we discuss the recent nanotechnological strategies for siRNA delivery by using different carriers such as liposomes, dendrimers and carbon nanotubes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796160     DOI: 10.1016/j.biomaterials.2012.06.068

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  69 in total

Review 1.  Delivery materials for siRNA therapeutics.

Authors:  Rosemary Kanasty; Joseph Robert Dorkin; Arturo Vegas; Daniel Anderson
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

Review 2.  Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.

Authors:  David J Mc Carthy; Meenakshi Malhotra; Aoife M O'Mahony; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

Review 3.  Transfection by cationic gemini lipids and surfactants.

Authors:  M Damen; A J J Groenen; S F M van Dongen; R J M Nolte; B J Scholte; M C Feiters
Journal:  Medchemcomm       Date:  2018-07-17       Impact factor: 3.597

4.  Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction.

Authors:  Jie Liu; Catherine Gu; E Bernadette Cabigas; Karl D Pendergrass; Milton E Brown; Ying Luo; Michael E Davis
Journal:  Biomaterials       Date:  2013-02-19       Impact factor: 12.479

5.  Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.

Authors:  Kirk K Hou; Hua Pan; Lee Ratner; Paul H Schlesinger; Samuel A Wickline
Journal:  ACS Nano       Date:  2013-09-26       Impact factor: 15.881

6.  Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations.

Authors:  Prashant Kesharwani; Rakesh K Tekade; Narendra K Jain
Journal:  Pharm Res       Date:  2014-10-18       Impact factor: 4.200

7.  In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo.

Authors:  Larissa Bueno Tofani; Lívia Vieira Depieri; Patrícia Mazureki Campos; Thalita Bachelli Riul; Kamilla Swiech Antonietto; Márcia Carvalho de Abreu Fantini; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2018-03-20       Impact factor: 4.200

8.  Engineering a customized nanodrug delivery system at the cellular level for targeted cancer therapy.

Authors:  Jin Li; Liping Qiu; Sitao Xie; Jing Zhang; Liqin Zhang; Honglin Liu; Juan Li; Xiaobing Zhang; Weihong Tan
Journal:  Sci China Chem       Date:  2018-01-11       Impact factor: 9.445

Review 9.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

Review 10.  Non-viral nanocarriers for siRNA delivery in breast cancer.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  J Control Release       Date:  2014-05-27       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.